Kindred Biosciences Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
33.8 M |
Public Float |
20.47 M |
Kindred Biosciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.66 |
Market Cap |
$321.4 M |
Shares Outstanding |
39.01 M |
Public Float |
36.38 M |
Address |
1555 Bayshore Highway Burlingame California 94010 United States |
Employees | - |
Website | http://www.kindredbio.com |
Updated | 07/08/2019 |
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. |